The real-time polymerase chain reaction( PCR) has become a key tool for molecular assay development, expanding into applications as diverse as in vitro diagnostics (IVDs), food safety testing, and ...

Novacyt said today it will acquire molecular diagnostics developer Primer Design for up to £12.35 million ($17.6 million) in a deal the buyer said would complement and expand its molecular diagnostics ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time ...

Sample volumes that are gradually increasing and innovative options for molecular biology experiments are altering the demands on quantitative real-time PCR. Migrating to the multi-well format with ...